Dorsch Marion 4
4 · Blueprint Medicines Corp · Filed Mar 3, 2020
Insider Transaction Report
Form 4
Dorsch Marion
Chief Scientific Officer
Transactions
- Award
Common Stock
2020-03-01+10,000→ 17,000 total - Award
Stock Option (Right to Buy)
2020-03-01+20,000→ 20,000 totalExercise: $54.13Exp: 2030-03-01→ Common Stock (20,000 underlying)
Footnotes (2)
- [F1]The reported transaction involved the Reporting Person's receipt of a grant of 10,000 restricted stock units under Issuer's 2015 Stock Option and Incentive Plan. The Reporting Person has reported prior awards of restricted stock units in Table II of Form 4. The total reported in Column 5 includes the 10,000 newly awarded restricted stock units, and 7,000 previously reported restricted stock units, 1,750 of which vested on March 1, 2020.
- [F2]This option vests with respect to 1/48th of the shares underlying the option on April 1, 2020 and as to an additional 1/48th of the shares underlying the option each month thereafter.